ClinicalTrials.Veeva

Menu

Self-assembling Peptide With Sodium Fluoride in Treating White Spot Lesionss in Primary Teeth

H

Hams Hamed Abdelrahman

Status

Completed

Conditions

White Spot Lesion

Treatments

Other: Fluoride varnish (DURAFLOR
Other: Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR

Study type

Interventional

Funder types

Other

Identifiers

NCT05721586
P11-4_2020

Details and patient eligibility

About

Regenerative medicine-based approaches for caries treatment focus on biomimetic remineralization of initial carious lesions as a minimally invasive therapy using Self-Assembling Peptide P11-4 (CURODONTTM REPAIR) which enhances remineralization of white spot lesions (WSLs). The study aimed to assess clinically the effect of Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR) versus a 5% fluoride varnish (DURAFLOR) on remineralization of enamel White Spot Lesions in primary teeth.

Enrollment

24 patients

Sex

All

Ages

3 to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • children with high caries risk with the presence of at least one visible active WSL in primary teeth with ICDAS II score of 1, 2 or 3

Exclusion criteria

  • Children with systemic diseases
  • Teeth with cavitated lesion involving dentin and enamel defects

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

24 participants in 2 patient groups

CURODONTTM REPAIR: + Fluoride varnish (DURAFLOR)
Experimental group
Treatment:
Other: Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR
Fluoride Varnish (DURAFLOR) only
Active Comparator group
Treatment:
Other: Fluoride varnish (DURAFLOR

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems